Press Releases

Press Releases

Congratulations to Stanford Medicine on winning the 2023 Hearst Health Prize for its artificial intelligence solution that helps identify patients at risk for heart attack by scoring incidental coronary artery calcium (CAC) on non-gated chest CTs.

Predictive model generation for pre-planning a cardiac procedure now reimbursable by Medicare at approximately $1,000 per model

 

Late-Breaking Science sessions reveal revolutionary findings on severe aortic stenosis and mild-to-severe mitral regurgitation identification through innovative AI technology.

 

Aug 15, 2023 | Submitted by: Keystone Perfusion Services, PC

The company's multifaceted healthcare staffing solutions play a pivotal role in transforming patient care and elevating industry standards.

 

The agreement formally endorses Corazon’s cardiovascular accreditation.

Arineta Cardio Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT scanners.

 

Researchers and engineers at Mayo Clinic and Ultromics developed technology that can detect HFpEF using a single A4C echocardiogram clip, to help clinicians detect a complex form of heart failure easily and accurately. 

 

The Midwest company will begin offering EchoSolv, an artificial intelligence clinical decision support platform designed to help detect severe aortic stenosis, to providers throughout the country.

 

Jun 14, 2023 | Submitted by: DASI Simulations

Precision TAVI is the first FDA-approved predictive modeling tool for medical teams planning TAVR procedures.

 

 

RecoverRite’s Online Heart Learning Center to feature ACC’s CardioSmart patient tools and resources.

PulseAI, a leader in the development of cutting-edge AI-powered ECG software, has released the results of a clinical study that has shown the superiority of its deep learning AI over the Apple Watch ECG algorithm in the detection of atrial fibrillation.

 

NAPLES, Fla. – February 20, 2023   The NCH Healthcare System is proud to announce a $20 million naming gift from the Rooney Foundation, which is the philanthropic arm of the former U.S. Representative for Florida's 19th congressional district and his wife, Francis and Kathleen Rooney.  In recognition of increasing their $8 million pledge announced last July, the entire cardiac program across NCH Healthcare System will be renamed “The Rooney Heart Institute.”

NAPLES, Fla. – February 21, 2023   On the heels of our historic $20 Million gift announcement made last week, NCH is proud to announce yet a second $20 million naming gift in as many weeks from Diana and Don Wingard.  This generous gift will provide the necessary funds to ensure that the NCH Stroke program continues to provide the highest level of care and treatment to patients in Southwest Florida.  Additionally, in recognition of the extraordinary pledge, the entire stroke program across NCH will be renamed the “Wingard Stroke Institute.”

When using this service, patients have the ability to upload and share data without limitations. From radiology CDs to PDFs or JPG files, patients can use their smartphone connected to the Patient Image Exchange app and upload images, share lab results, immunizations records, nurses’ notes, dental images and much more.

 

Ancora Heart has hired senior financial leader David J. Tucker as its chief financial officer. This is the company's second C-suite hire in 2022, following the addition of Mark Miles as chief commercial officer in June.

Geneticure, a global leader in the genetic variability of response to hypertension treatments, presented data at the 2022 American Heart Association Scientific Sessions meeting from a recent clinical study in which they were able to successfully predict patients who will respond to renal denervation (RDN). In addition, the Geneticure test for renal denervation also identified patients with an increase in blood pressure, following the procedure.

Long-awaited milestone gives physicians and their patients greater access to prescription cardiac arrhythmia detection solutions, including the company’s Cardea SOLO™ ECG System

An American Heart Association/American Stroke Association sponsored study comparing which stroke therapies work best has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI).

Bayer HealthCare today announced that the U.S. Food and Drug Administration's (FDA) Office of Orphan Products Development has granted two separate orphan drug designations for its investigational, oral medication riociguat, proposed trade name Adempas®, for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The Orphan Drug Designation program provides orphan status to drugs and biologics that are defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases and disorders that affect fewer than 200,000 people in the U.S., or that affect more than 200,000 persons but are not expected to recover the costs of developing and marketing a treatment drug.

Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the number of patients enrolled in the company's REDUCE-IT cardiovascular outcomes study of Vascepa(R) (icosapent ethyl) capsules has surpassed 6,000.

The Canadian Medical Hall of Fame is proud to announce the 2014 inductees. Their passion and innovative, visionary leadership has improved health worldwide. The six inductees announced today will join the ranks of 101 laureates who have gone before them in receiving this prestigious national honour.

The American College of Cardiology this morning kicked off its annual Legislative Conference, an event that will culminate with nearly 400 cardiovascular professionals heading to Capitol Hill on Tuesday to promote quality care for heart patients across the nation.

Atherotech Diagnostics Lab, a leading clinical reference laboratory specializing in cardiometabolic testing and disease management solutions, announces the addition of Gerard Abate, M.D., as the company’s Chief Clinical Officer.

Marc Cribbs, M.D., has joined the University of Alabama at Birmingham Division of Cardiovascular Disease as director of the new Alabama Adult Congenital Heart Disease Program.

The University of Nevada, Las Vegas (UNLV) and Nevada Senator Harry Reid announced a five-year, $20.3 million grant awarded to UNLV from the National Institutes of Health (NIH) to lead a health research network of 13 universities across the Mountain West. The University of Nevada School of Medicine will partner on the grant.

Gov. Rick Perry today announced a $3 million investment through the Texas Emerging Technology Fund (TETF) to create the Center for Cell and Organ Biotechnology in collaboration with the Texas Heart Institute (THI) and Texas A&M University College of Veterinary Medicine and Biomedical Sciences.

Symphony Health Solutions, a provider of high-value data, analytics and technology solutions for life science manufacturers, payers and providers, and the American College of Cardiology (ACC), a professional organization dedicated to improving cardiovascular health, today announced they have entered into a business relationship to develop new insights from an integrated healthcare database, which will include assets from the ACC’s rich National Cardiovascular Data Registry (NCDR) and Symphony Health’s Integrated DataverseTM.

Dr. R. Clinton Webb, Chairman of the Department of Physiology at the Medical College of Georgia at Georgia Regents University, is the 2013 recipient of the American Heart Association Council on High Blood Pressure Research's Irvine Page-Alva Bradley Lifetime Achievement Award.

Faced with a disparate array of information technology (IT) products throughout its 19 facilities located in the state of Virginia, Sentara Healthcare selected Medstreaming Vascular Software Solutions and began an enterprise-wide installation late last year. Post-installation, Sentara officials have reported significant efficiency gains in patient throughput, report standardization, quality and workflow.

Dr. Emerson Perin, director of the Texas Heart Institute (THI) Stem Cell Center and of Clinical Research for Cardiovascular Medicine, has been named a McNair Scholar at THI.

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the CE Mark approval of its next-generation EnligHTN™ Renal Denervation System for treating patients with drug-resistant, uncontrolled hypertension. The system features an advanced generator that delivers simultaneous ablations via a multi-electrode catheter, reducing total ablation time with the new EnligHTN system by more than 80 percent in comparison to the first generation system, from approximately 24 minutes to four minutes. The EnligHTN system will be on display during the 2013 European Society of Cardiology (ESC) meeting from August 31 to September 3.

Cleveland HeartLab Inc. (CHL), a rapidly growing specialty clinical laboratory and cardiovascular disease management company, today announced that its fourth annual symposium, Where Inflammation Meets Lipids®, will focus on unique models and strategies for assessing, treating and preventing chronic disease.

On Thursday evening, the Montreal Heart Institute (MHI) inaugurated its brand new Philippa and Marvin Carsley Cardiovascular Magnetic Resonance Centre, in honour of the loyal donors. Their generous contribution will allow the MHI to operate this equipment, positioning our hospital as one of the leading cardiology centres specialized in cardiovascular imaging.

Nurses caring for acutely or critically ill cardiovascular patients can take heart: The American Association of Critical-Care Nurses (AACN) offers online educational support for cardiac nurses interested in deepening their expertise and acquiring subspecialty certification.

Effective October 1, Cook Medical’s Zilver® PTX® Drug-Eluting Peripheral Stent qualifies for new-technology add-on payments under Medicare’s hospital inpatient prospective payment system.

The directors of CVPath Institute, a leading cardiovascular research organization, have appointed Dr. Michael Joner as the Institute's new Chief Executive Officer, announced Dr. Renu Virmani, CVPath's founder, president and medical director. His appointment became effective August 15, 2013.  

The Spectranetics Corporation (Nasdaq:SPNC), a leading maker of medical devices used in minimally invasive cardiovascular procedures, today announced the appointment of Kimberly McIntosh Bridges as Senior Vice President, Sales and Marketing, Vascular Intervention, effective August 30, 2013. She will report to Scott Drake, President and Chief Executive Officer, and will be located at the company's global headquarters in Colorado Springs, CO.

Christopher Adams, M.D., a cardiology fellow with the department of cardiology, Joan C. Edwards School of Medicine, recently received the James Willerson Clinical Award Competition for Residents and Fellows from the International Academy of Cardiovascular Sciences (IACS).  The award was established to promote, encourage and recognize young talents in cardiovascular science, medicine and surgery.